查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031 年歐洲藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1819689

2021-2031 年歐洲藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）

Europe Pharmacovigilance and Drug Safety Software Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 224 Pages | 訂單完成後即時交付

價格

2023 年歐洲藥物警戒和藥物安全軟體市場價值約為 5,238 萬美元，預計到 2031 年將成長到 8,467 萬美元，在此期間的年複合成長率(CAGR) 為 6.2%。

藥物警戒全球化：市場成長的催化劑

藥物警戒涉及對藥物不良反應 (ADR) 的監測和評估，是藥品監管、臨床實踐和公共衛生計劃的關鍵環節。藥物警戒的全球化正在促進各利益相關者（包括監管機構、醫療保健提供者和製藥公司）之間加強合作。例如，歐洲藥品管理局 (EMA) 日益強調藥品監管機構之間國際合作的重要性，重點在於藥品安全、檢查和相關資訊交流。這種合作框架不僅促進了資料共享，也增進了對藥品安全性的整體理解。

隨著企業力求利用這些全球網路，對能夠跨境有效運作的綜合藥物警戒解決方案的需求日益凸顯。世界各國政府正與本國監管機構合作實施藥物警戒計劃，並承認藥物警戒在確保藥品安全方面的重要作用。各國對藥物警戒的認知不斷提高，並紛紛採用最佳實踐，這顯著增加了對專業軟體解決方案的需求。一個顯著的例子是義大利醫療機構，該機構於2022年6月啟動了國家藥物警戒網路 (RNF)，以檢測疑似不良反應 (ADR)。該系統整合了管理和分析ADR報告的先進功能，確保對藥品安全性進行準確評估。此外，歐洲各國普遍使用的EudraVigilance系統可以產生疑似ADR報告，進一步加強了藥物警戒工作。

藥物警戒的全球化也促進了跨國合作。一些歐洲計劃，例如比荷盧經濟聯盟、北歐合作組織和《瓦萊塔宣言》，旨在改善患者獲得創新療法的管道。例如，比荷盧經濟聯盟計劃加強了比利時、荷蘭、盧森堡、奧地利和愛爾蘭之間的合作，使中等收入國家能夠協商更優惠的藥品定價並分享政策專業知識。這些合作努力支持全面的衛生技術評估，並提高藥品行銷的透明度。建立一個能夠在全球範圍內管理和報告藥品不良反應的強大藥物警戒系統，對於推進藥物警戒的全球化至關重要，從而推動藥物警戒和藥物安全軟體市場的成長。

歐洲藥物警戒與藥品安全軟體市場概況

歐洲對藥物警戒和藥物安全軟體的需求不斷成長，這可歸因於多種因素，包括嚴格的監管要求、藥品核准數量的增加、對病人安全的高度重視以及技術進步。歐盟的藥物警戒框架是全球最完善的框架之一，EMA 等監管機構執行嚴格的藥物警戒標準，這要求採用先進的軟體解決方案。歐盟藥物警戒指令 (2010/84/EU) 和法規 (EU) No 1235/2010 引入了更嚴格的藥品不良反應 (ADR) 監測規則，強制公司即時報告安全資料，並增加了對能夠處理大量資料的高效軟體系統的需求。

歐洲製藥業新藥核准數量激增，進一步推動了對藥物警戒和藥物安全軟體的需求，以有效監測安全資料。例如，2023年第二季度，歐洲藥品管理局（EMA）和美國食品藥物管理局（FDA）批准了超過21種新的腫瘤藥物。隨著越來越多的產品進入市場，製藥公司需要強大的軟體解決方案來確保這些藥物的安全性和有效性。甲骨文公司等大型公司正大力投資藥物警戒軟體，以增強其對新核准產品的安全監測能力，並利用Oracle Argus Safety和Veeva Vault Safety等平台進行有效的不良事件管理。

此外，歐洲各國政府正在實施合規措施以保護軟體資料，尤其是在歐盟《一般資料保護規範》（GDPR）推出後。該條例規定，藥物警戒和藥物安全軟體不僅要符合監管標準，還要確保營運效率，同時保護資料隱私。遵守GDPR對於維護患者和監管機構的信任至關重要，從而促進藥物警戒軟體在歐洲的普及。

人工智慧 (AI)、機器學習 (ML) 和其他先進技術的融合正在徹底改變藥物警戒流程。這些創新促進了自動化資料處理、即時訊號檢測和進階分析，從而簡化了安全資料管理和法規合規性。例如，ArisGlobal 的 LifeSphere 平台利用人工智慧實現案例處理自動化並增強訊號檢測能力，進一步推動了歐洲對藥物警戒和藥物安全軟體的需求。

市場區隔分析

歐洲藥物警戒和藥物安全軟體市場根據各種標準進行細分，包括產品、部署、企業規模、形式、功能、最終用戶和國家。

  • 產品：市場分為軟體和服務，其中軟體部分在 2023 年將佔據更大的佔有率。
  • 部署：市場分為雲端解決方案和本地解決方案，其中雲端解決方案在 2023 年占主導地位。
  • 企業規模：市場分為大型企業和中小企業，其中大型企業佔有相當大的佔有率。
  • 形式：市場分為標準解決方案和客製化解決方案，其中標準解決方案在市場佔有率中領先。
  • 功能：市場包括訊號和風險管理、問題追蹤、案例管理等，其中訊號和風險管理是最大的部分。
  • 最終用戶：市場分為製藥和生物技術公司、合約研究組織和 BPO 公司，其中製藥和生物技術公司處於領先地位。
  • 國家：市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區，其中德國在 2023 年佔據市場佔有率的主導地位。

市場關鍵參與者

歐洲藥物警戒和藥物安全軟體市場的領先公司包括 Veeva Systems Inc、IQVIA Holdings Inc、AB Cube SAS、ArisGlobal LLC、Oracle Corp、Max Application、ICON Plc、Cognizant Technology Solutions Corp、Accenture Plc、Syneos Health Inc、Genpact Ltd.、Laboratory Corp of America Holdings、Parexsa Technologies、Qline）。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲藥物警戒與藥品安全軟體市場格局

  • 4.1 概述
  • 生態系分析
    • 軟體/服務提供者：
    • 系統整合商：
    • 監理機構：
    • 最終用戶：
    • 價值鏈中的供應商列表

第5章：歐洲藥物警戒與藥品安全軟體市場－關鍵市場動態

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響：

第6章：歐洲藥物警戒與藥品安全軟體市場 - 分析

  • 2021-2031年歐洲藥物警戒與藥物安全軟體市場收入
  • 歐洲藥物警戒與藥品安全軟體市場預測分析

第7章：歐洲藥物警戒與藥品安全軟體市場分析-依產品

  • 軟體
  • 服務

第 8 章：歐洲藥物警戒與藥品安全軟體市場分析 - 按部署

  • 雲
  • 本地

第9章：歐洲藥物警戒與藥品安全軟體市場分析－依企業規模

  • 大型企業
  • 中小企業

第 10 章：歐洲藥物警戒和藥品安全軟體市場分析 - 按形式

  • 標準
  • 客製化

第 11 章：歐洲藥物警戒與藥品安全軟體市場分析 - 按功能

  • 訊號和風險管理
  • 問題追蹤和不良事件追蹤
  • 案件管理
  • 臨床安全管理與臨床試驗安全
  • 品質與合規
  • 醫學寫作
  • 審計支援和培訓合規性
  • 醫療保健分析
  • 其他

第 12 章：歐洲藥物警戒和藥品安全軟體市場分析 - 按最終用戶

  • 製藥和生物技術公司
  • 合約研究組織
  • 業務流程外包（BPO）公司
  • 其他

第 13 章：歐洲藥物警戒與藥品安全軟體市場 - 國家分析

  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 14 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第15章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作

第 16 章：公司簡介

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第 17 章：附錄

Product Code: TIPRE00022771

The pharmacovigilance and drug safety software market in Europe was valued at approximately US$ 52.38 million in 2023, with projections indicating it will grow to US$ 84.67 million by 2031, reflecting a compound annual growth rate (CAGR) of 6.2% during this period.

Globalization of Pharmacovigilance: A Catalyst for Market Growth

Pharmacovigilance, which involves the monitoring and assessment of adverse drug reactions (ADRs), is a critical aspect of drug regulation, clinical practice, and public health initiatives. The globalization of pharmacovigilance is fostering enhanced collaboration among various stakeholders, including regulatory authorities, healthcare providers, and pharmaceutical companies. For example, the European Medicines Agency (EMA) has increasingly emphasized the importance of international cooperation among pharmaceutical regulators, focusing on medicine safety, inspections, and the exchange of pertinent information. This collaborative framework not only facilitates data sharing but also improves the overall understanding of drug safety profiles.

As companies aim to capitalize on these global networks, the demand for integrated pharmacovigilance solutions that can function effectively across borders is becoming more pronounced. Governments worldwide are implementing pharmacovigilance programs in partnership with their national regulatory bodies, recognizing the vital role of pharmacovigilance in ensuring drug safety. The growing awareness and adoption of best practices in pharmacovigilance across various countries have significantly increased the demand for specialized software solutions. A notable example is Italy's Medical Agency, which launched the National Pharmacovigilance Network (RNF) in June 2022 to detect suspected ADRs. This system incorporates advanced functionalities for managing and analyzing ADR reports, ensuring accurate assessments of medicine safety. Additionally, the EudraVigilance System, utilized across European nations, generates reports on suspected ADRs, further enhancing pharmacovigilance efforts.

The globalization of pharmacovigilance also promotes cross-border collaboration. Several European initiatives, such as BeNeLuxA, the Nordic collaborations, and the Valletta Declaration, aim to improve patient access to innovative therapies. The BeNeLuxA initiative, for instance, enhances cooperation among Belgium, the Netherlands, Luxembourg, Austria, and Ireland, allowing middle-income countries to negotiate better drug pricing and share policy expertise. These collaborative efforts support comprehensive health technology assessments and improve transparency in pharmaceutical marketing. The establishment of robust pharmacovigilance systems capable of managing and reporting ADRs on a global scale is essential for advancing the globalization of pharmacovigilance, thereby driving the growth of the pharmacovigilance and drug safety software market.

Overview of the Europe Pharmacovigilance and Drug Safety Software Market

The increasing demand for pharmacovigilance and drug safety software in Europe can be attributed to several factors, including stringent regulatory requirements, a rise in drug approvals, a heightened focus on patient safety, and technological advancements. The EU's pharmacovigilance framework is among the most sophisticated globally, with regulatory bodies like the EMA enforcing rigorous pharmacovigilance standards that necessitate the adoption of advanced software solutions. The EU Pharmacovigilance Directive (2010/84/EU) and Regulation (EU) No 1235/2010 have introduced stricter monitoring rules for ADRs, compelling companies to report safety data in real-time and increasing the need for efficient software systems capable of handling large data volumes.

The European pharmaceutical sector has witnessed a surge in new drug approvals, further driving the demand for pharmacovigilance and drug safety software to monitor safety data effectively. For instance, in the second quarter of 2023, the EMA and the US FDA approved over 21 new oncology drugs. As more products enter the market, pharmaceutical companies require robust software solutions to ensure the safety and efficacy of these drugs. Major companies, such as Oracle Corp, are heavily investing in pharmacovigilance software to enhance their safety monitoring capabilities for newly approved products, utilizing platforms like Oracle Argus Safety and Veeva Vault Safety for effective adverse event management.

Moreover, European governments are implementing compliance measures to protect software data, particularly with the introduction of the EU General Data Protection Regulation (GDPR). This regulation mandates that pharmacovigilance and drug safety software not only meet regulatory standards but also ensure operational efficiency while safeguarding data privacy. Adhering to GDPR is crucial for maintaining trust with patients and regulatory bodies alike, thereby boosting the adoption of pharmacovigilance software across Europe.

The integration of artificial intelligence (AI), machine learning (ML), and other advanced technologies is revolutionizing pharmacovigilance processes. These innovations facilitate automated data processing, real-time signal detection, and advanced analytics, simplifying the management of safety data and compliance with regulatory requirements. For example, ArisGlobal's LifeSphere platform leverages AI to automate case processing and enhance signal detection capabilities, further driving the demand for pharmacovigilance and drug safety software in Europe.

Market Segmentation Analysis

The Europe pharmacovigilance and drug safety software market is segmented based on various criteria, including offering, deployment, enterprise size, form, functionality, end user, and country.

  • Offering: The market is divided into software and services, with the software segment holding a larger share in 2023.
  • Deployment: The market is categorized into cloud and on-premises solutions, with cloud solutions dominating in 2023.
  • Enterprise Size: The market is segmented into large enterprises and SMEs, with large enterprises holding a significant share.
  • Form: The market is classified into standard and customized solutions, with standard solutions leading in market share.
  • Functionality: The market includes signal and risk management, issue tracking, case management, and more, with signal and risk management being the largest segment.
  • End User: The market is divided into pharmaceutical and biotechnology companies, contract research organizations, and BPO firms, with pharmaceutical and biotechnology companies leading.
  • Country: The market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe, with Germany dominating the market share in 2023.

Key Players in the Market

Leading companies in the Europe pharmacovigilance and drug safety software market include Veeva Systems Inc, IQVIA Holdings Inc, AB Cube S.A.S., ArisGlobal LLC, Oracle Corp, Max Application, ICON Plc, Cognizant Technology Solutions Corp, Accenture Plc, Syneos Health Inc, Genpact Ltd., Laboratory Corp of America Holdings, Parexel International Corp, Qinecsa Solutions, and Clinevo Technologies.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
  • 4.2 Ecosystem Analysis
    • 4.2.1 Software/Service Providers:
    • 4.2.2 System Integrators:
    • 4.2.3 Regulatory Bodies:
    • 4.2.4 End-Users:
    • 4.2.5 List of Vendors in the Value Chain

5. Europe Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1 Market Drivers
  • 5.2 Market Restraints
  • 5.3 Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact of Drivers and Restraints:

6. Europe Pharmacovigilance and Drug Safety Software Market - Analysis

  • 6.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Europe Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.1 On Premises: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.1 SMEs: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

10. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.1 Customized: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

11. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.1 Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.1 Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.1 Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.1 Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.1 Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.1 Others: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

12. Europe Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.1 Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.1 Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.1 Others: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

13. Europe Pharmacovigilance and Drug Safety Software Market - Country Analysis

  • 13.1 Europe
    • 13.1.1 Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.1 Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.2.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.2.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.2.3 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.2.4 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.2.5 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.2.6 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.3 France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.3.1 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.3.2 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.3.3 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.3.4 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.3.5 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.3.6 France: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.4.1 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.4.2 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.4.3 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.4.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.4.5 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.4.6 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.5.1 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.5.2 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.5.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.5.4 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.5.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.5.6 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.6.1 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.6.2 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.6.3 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.6.4 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.6.5 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.6.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.7 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.7.1 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.7.2 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.7.3 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.7.4 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.7.5 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.7.6 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share - by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning and Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Partnerships and Collaborations

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Description
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 About Us
  • 17.2 List of Abbreviations

List Of Tables

  • Table 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Table 4. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Offering
  • Table 5. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Deployment
  • Table 6. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Enterprise Size
  • Table 7. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Form
  • Table 8. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Functionality
  • Table 9. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User
  • Table 10. Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country
  • Table 11. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 12. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 13. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 14. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 15. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 16. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 17. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 18. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 19. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 20. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 21. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 22. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 23. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 24. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 25. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 26. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 27. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 28. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 29. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 30. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 31. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 32. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 33. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 34. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 35. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 36. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 38. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 39. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 40. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 41. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 42. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 43. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 44. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 45. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 46. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 47. List of Abbreviations

List Of Figures

  • Figure 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation - Country
  • Figure 2. Europe Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 6. Software: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 7. Services: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 8. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 9. Cloud: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 10. On Premises: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 11. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 12. Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 13. SMEs: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 14. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 15. Standard: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 16. Customized: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 17. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 18. Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 19. Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 20. Case Management: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 21. Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 22. Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 23. Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 24. Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 25. Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 26. Others: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 27. Europe Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 28. Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 29. Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 30. Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 31. Others: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 32. Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. Germany: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 34. France: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 35. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 36. Italy: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 38. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 39. Heat Map Analysis by Key Players
  • Figure 40. Company Positioning and Concentration